Document Type : Original Article(s)

Authors

• Masoumeh Ghoddusi Johari ¹
• Hamid Reza Tabatabaee ²
• Babak Shirazi Yeganeh ³
• Najmeh Maharloue ⁴
• Sedigheh Tahmasebi ¹
• Abbas Rezaianzadeh ²

¹ Breast Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

² Epidemiology Department, Shiraz University of Medical Sciences, Shiraz, Iran

³ Pathology Department, Shiraz University of Medical Sciences, Shiraz, Iran

⁴ Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran

Abstract

Background: Bronchus and lung cancer (BLC) is the first most prevalent cancer in terms of incidence and mortality worldwide. It is estimated that the number of new BLC cases will rise up to 15 million per year by 2020.
Method: We conducted this study using the data obtained from Fars Population Based Cancer Registry (FPBCR). The National Institute of Statistics (NIS) website provided the population data on Fars province. Additionally, we calculated the ASR through the WHO’s standard population 2000. The standardized rates were calculated via R software and the rate trends were analyzed using chi-square test.
Result: Over a 5-year period (2011-2015), 1466 new BLC cases were registered in Fars province, 1009 men (68.8%) and 437 women (31.2%). BLC was amongst the first 10 most prevalent cancers in both genders. The annual incidence rate of BLC was defined to be 7.69-10.78 per 100,000 among men and 3.00-4.52 per 100,000 among women.
Conclusion: BLC is amongst the most prevalent cancers with geographical variations in incidence rates. Consistent with cancer reports from other province, relatively high rates of BLC were observed in Fars province, particularly among men.

Keywords

• Lung cancer
• Incidence
• Population-based cancer registry
• Trend